Showing results (141-150 of 148) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Journal of Experimental & Clinical Cancer Research : CR|May 23, 2018
The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcomaHye Jeong Park, Jun Sang Bae, Kyoung Min Kim, et al.Bone|May 16, 2009
COMP-Angiopoietin-1 ameliorates surgery-induced ischemic necrosis of the femoral head in ratsByung-Hyun Park, Kyu Yun Jang, Kyu Hyung Kim, et al.Journal of Experimental & Clinical Cancer Research : CR|November 17, 2020
Inhibition of SIRT6 potentiates the anti-tumor effect of doxorubicin through suppression of the DNA damage repair pathway in osteosarcomaZhongkai Zhang, Sang Hoon Ha, Young Jae Moon, et al.Journal of Experimental & Clinical Cancer Research : CR|June 20, 2019
FAM83H is involved in stabilization of β-catenin and progression of osteosarcomasKyoung Min Kim, Usama Khamis Hussein, See-Hyoung Park, et al.Scientific Reports|June 14, 2017
FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYCKyoung Min Kim, See-Hyoung Park, Jun Sang Bae, et al.The American Journal of Pathology|October 18, 2016
CK2α/CSNK2A1 Phosphorylates SIRT6 and Is Involved in the Progression of Breast Carcinoma and Predicts Shorter Survival of Diagnosed PatientsJun Sang Bae, See-Hyoung Park, Urangoo Jamiyandorj, et al.Clinical Therapeutics|November 19, 2008
Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I studyKyoung Soo Lim, Jung-Ryul Kim, Yun-Jung Choi, et al.Arthritis and Rheumatism|June 1, 2006
CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritisHak-Yong Lee, Hyun-Soon Jeon, Eun-Kyung Song, et al.Pageof 15